Cargando…

Dietary intervention, a promising adjunct for cancer therapy

Detalles Bibliográficos
Autores principales:	Shi, Rongchen, Miao, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445236/ https://www.ncbi.nlm.nih.gov/pubmed/32839431 http://dx.doi.org/10.1038/s41392-020-00271-y

Ejemplares similares

Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
por: Xiang, Yuancai, et al.
Publicado: (2020)

Targeting metabolic/epigenetic pathways: a potential strategy for cancer therapy in diffuse intrinsic pontine gliomas
por: Zhao, Kun, et al.
Publicado: (2020)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Ketogenic diet: new avenues to overcome colorectal cancer
por: Xiang, Yuancai, et al.
Publicado: (2022)

Bispecific immune molecule PD1-IL2v: a new therapeutic strategy for pancreatic ductal adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2023)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Proteomics promises a new era of precision cancer medicine
por: Wu, Chong, et al.
Publicado: (2019)

FAP senescence: a critical event in muscle regeneration
por: Kang, Xia, et al.
Publicado: (2023)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

Artemisinin: A Promising Adjunct for Cancer Therapy
por: Waseem, Yamna, et al.
Publicado: (2018)

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers
por: Xu, Rongyang, et al.
Publicado: (2023)

A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

Metabolism in tumor microenvironment: Implications for cancer immunotherapy
por: Shi, Rongchen, et al.
Publicado: (2020)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

Promising biotechnological applications of antibiofilm exopolysaccharides
por: Bernal, Patricia, et al.
Publicado: (2012)

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
por: Yu, Bin, et al.
Publicado: (2020)

Base editing: a promising tool to rescue spinal muscular atrophy
por: Bhatia, Priyanka, et al.
Publicado: (2023)

Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer
por: Mi, Mi, et al.
Publicado: (2022)

Surrogate cytokine agonists: promising agents against COVID-19
por: Lin, Zemin, et al.
Publicado: (2022)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Margetuximab: An active alternative for later‐line therapy in patients with HER2‐positive advanced breast cancer
por: Zhou, Yunxiang, et al.
Publicado: (2023)

A P4 Medicine Perspective of Gut Microbiota and Prediabetes: Systems Analysis and Personalized Intervention
por: Huang, Qiongrong, et al.
Publicado: (2020)

On the road to epigenetic therapy
por: Walton, Emma L.
Publicado: (2016)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

High-throughput base editing: a promising technology for precision medicine and drug discovery
por: Sachinidis, Agapios
Publicado: (2021)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

The expanding world of stem cell modeling of Huntington's disease: creating tools with a promising future
por: Ward, Jacqueline M, et al.
Publicado: (2012)

Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages
por: Xiang, Wei, et al.
Publicado: (2020)

Rab22a-NeoF1: a promising target for osteosarcoma patients with lung metastasis
por: Xie, Kai, et al.
Publicado: (2020)

Who Has Therapy-Related AML?
por: Gale, Robert Peter, et al.
Publicado: (2017)

Towards gene therapy for IPEX syndrome
por: Borna, Simon, et al.
Publicado: (2022)

Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

A promising small molecule binding pocket in class B GPCRs: expanding potential for drug development
por: Xiao, Huan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kfjkps1af6mmggpg1jj4crku1c